The objective of the Populations and Measurement Core is to advise and support individual Projects to explore population differences and in various research methods such as sampling, formative and qualitative approaches, and quantitative methods. This Core will advise and support individual Projects on their studies on HER2/neu testing and trastuzumab therapy, Lynch Syndrome screening, and gene expression profiling (GEP). We will recommend various methodological and measurement approaches that will improve the quality and scientific relevance of the research for diverse populations.
Specific Aims Aim 1: To provide methodological and statistical support for all Projects, both overall and with the explicit focus on measuring variations in personalized medicine in diverse populations. The Core will: provide expertise on design and analysis across all Projects, including psychometric, quantitative, qualitative, and mixed methods. ? expand our measurement expertise by leveraging other resources of the University of California (UC) in San Francisco (UCSF) and Los Angeles (UCLA) that have well-established resources and experts in methods and measurement of cancer disparities.
Aim 2 : To evaluate, integrate, and translate new knowledge generated by Projects into measures and resources that increase the relevance of study approaches and findings for diverse population groups. The Core will: objectively evaluate the ethical issues in the conduct of research and the interpretation and implication of findings on clinical practice. ? coordinate research symposia with the Dissemination and Administration Core. ? facilitate interactions between researchers and community-based organizations. provide the Dissemination and Administration Core with a list of selected references and annotation on helpful resources. lead the development of publications on specific subpopulations and measurement issues and themes that span across Projects.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA130818-03
Application #
8139195
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
2013-08-31
Budget Start
2010-09-01
Budget End
2013-08-31
Support Year
3
Fiscal Year
2010
Total Cost
$95,494
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Phillips, Kathryn A; Deverka, Patricia A; Sox, Harold C et al. (2017) Making genomic medicine evidence-based and patient-centered: a structured review and landscape analysis of comparative effectiveness research. Genet Med 19:1081-1091
Knight, Sara J; Mohamed, Ateesha F; Marshall, Deborah A et al. (2015) Value of Genetic Testing for Hereditary Colorectal Cancer in a Probability-Based US Online Sample. Med Decis Making :
Ponce, Ninez A; Ko, Michelle; Liang, Su-Ying et al. (2015) Early diffusion of gene expression profiling in breast cancer patients associated with areas of high income inequality. Health Aff (Millwood) 34:609-15
Phillips, Kathryn A; Labno, Anna (2014) Private Companies Providing Health Care Price Data: Who Are They and What Information do They Provide? J Manag Care Med 17:75-80
Pletcher, Mark J; Pignone, Michael; Earnshaw, Stephanie et al. (2014) Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes 7:276-84
Kilambi, Vikram; Johnson, F Reed; González, Juan Marcos et al. (2014) Valuations of genetic test information for treatable conditions: the case of colorectal cancer screening. Value Health 17:838-45
Phillips, Kathryn A; Ann Sakowski, Julie; Trosman, Julia et al. (2014) The economic value of personalized medicine tests: what we know and what we need to know. Genet Med 16:251-7
Ferrusi, Ilia L; Earle, Craig C; Trudeau, Maureen et al. (2013) Closing the personalized medicine information gap: HER2 test documentation practice. Am J Manag Care 19:838-44
Kuppermann, Miriam; Wang, Grace; Wong, Shirley et al. (2013) Preferences for outcomes associated with decisions to undergo or forgo genetic testing for Lynch syndrome. Cancer 119:215-25
Weitzel, Jeffrey N; Clague, Jessica; Martir-Negron, Arelis et al. (2013) Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network. J Clin Oncol 31:210-6

Showing the most recent 10 out of 43 publications